SaaS stocks tumbled 24.1%, but HUBS (3.5x P/S) & NOW (6.8x P/S) show strong growth, unlike SPT (0.7x P/S).
Pharma giants agree to lower US drug prices, up to 85% off, via TrumpRx.com. Valuations may shift.
TSLA dips 5% on missed deliveries; oil jumps 10% amid Iran fears. Markets rebound slightly.
CVLT boasts 26.6% billings growth & 81.4% gross margin; TDW shows 27.8% revenue growth & 14.8% FCF margin. VAC faces debt risks.
Zeta Global (ZETA) shows strong billings & revenue growth at 2.1x P/S, outperforming SFIX & PUBM.
KLAC's 16% revenue growth & 60.7% gross margin justify its 35x P/E. FNB & BKU face slower growth.
Oil tops $110/barrel on Iran tensions; stocks recover early losses amid market volatility.
Sponsored
Must Read